When people talk about saving wildlife, they often focus on numbers. Conversations center on how many deer live in a forest, ...
Compass Pathways announced that its investigational psilocybin treatment has successfully met its primary endpoint in a Phase 3 trial in depression.
Morning Overview on MSN
Magic mushroom therapy just jumped closer to FDA approval
The U.S. Food and Drug Administration issued its first formal guidance on how to design and run clinical trials for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results